首页> 外文期刊>Experimental and clinical transplantation >Switch From Beta-Thalassemia Major to Beta-Thalassemia Intermedia After Secondary Graft Failure
【24h】

Switch From Beta-Thalassemia Major to Beta-Thalassemia Intermedia After Secondary Graft Failure

机译:继发性移植失败后,从主要的β地中海贫血转变为中间的β地中海贫血

获取原文
           

摘要

In this article, we report a switch of β-thalassemia major to intermedia β-thalassemia after allogeneic bone marrow transplant of a 6-year-old girl from her HLA-matched brother. After stable mixed chimerism, the patient had a secondary graft rejection and returned to total recipient chimerism as assessed by real-time polymerase chain reaction assay. Nonetheless, with a medium hemoglobin rate of 89 g/L, she did not need further transfusions for 60 months after rejection. We conclude that complete loss of donor cells after bone marrow transplant for β-thalassemia major is compatible with a stable clinical state, probably due to a γ-globin gene demethylation that enhances γ-globin chain production and further allows constitution of a fetal hemoglobin rate compatible with free transfusion survival.
机译:在本文中,我们报道了从HLA匹配的兄弟中招募了一名6岁女孩的异体骨髓移植后,重度β地中海贫血向中度β地中海贫血的转变。稳定的混合嵌合体后,患者发生继发性移植排斥反应,并通过实时聚合酶链反应分析评估恢复为完全受体嵌合体。尽管如此,由于中度血红蛋白率为89 g / L,她在排斥后60个月内无需进一步输血。我们得出的结论是,重型β地中海贫血的骨髓移植后供体细胞的完全丢失与稳定的临床状态兼容,这可能是由于γ-球蛋白基因去甲基化增强了γ-球蛋白链的产生并进一步允许胎儿血红蛋白发生率的提高与自由输血生存相容。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号